POCARE Trademark

Trademark Overview

On Monday, August 31, 2020, a trademark application was filed for POCARE with the United States Patent and Trademark Office. The USPTO has given the POCARE trademark a serial number of 90148917. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, July 17, 2024. This trademark is owned by Orgenesis Inc.. The POCARE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; development of cell therapy products; development of technologies for the manufacture and processing of cells to be used as part of advance cell therapies
pocare

General Information

Serial Number90148917
Word MarkPOCARE
Filing DateMonday, August 31, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer, infectious diseases, auto-immune diseases, metabolic disorders, dermatological diseases and disorders, musculoskeletal disorders
Goods and ServicesPharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; development of cell therapy products; development of technologies for the manufacture and processing of cells to be used as part of advance cell therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOCTOMERA LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressGERMANTOWN, MD 20876
Party NameMORGENESIS LLC
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressGERMANTOWN, MD 20876
Party NameOrgenesis Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876
Party NameOrgenesis Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Trademark Events

Event DateEvent Description
Thursday, September 3, 2020NEW APPLICATION ENTERED
Monday, October 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 4, 2021ASSIGNED TO EXAMINER
Wednesday, January 6, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 6, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, January 6, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 6, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, January 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 19, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 2, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, April 13, 2021PRIORITY ACTION WRITTEN
Tuesday, April 13, 2021PRIORITY ACTION E-MAILED
Tuesday, April 13, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, October 25, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, October 25, 2021EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, October 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 1, 2022SOU EXTENSION 1 FILED
Tuesday, February 1, 2022SOU EXTENSION 1 GRANTED
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2022SOU EXTENSION 2 FILED
Thursday, December 22, 2022SOU EXTENSION 2 GRANTED
Saturday, December 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2023SOU EXTENSION 3 FILED
Thursday, June 22, 2023SOU EXTENSION 3 GRANTED
Saturday, June 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 4 FILED
Tuesday, January 16, 2024SOU EXTENSION 4 GRANTED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 17, 2024SOU EXTENSION 5 FILED
Wednesday, July 17, 2024SOU EXTENSION 5 GRANTED
Wednesday, January 31, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

pocare development pharmaceutical diseases disorders products cell therapies technologies therapy manufacture